TrialBMC infectious diseases2012

Significance of a reduction in HCV RNA levels at 4 and 12 weeks in patients infected with HCV genotype 1b for the prediction of the outcome of combination therapy with peginterferon and ribavirin.

Hidenori Toyoda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.